Frozen needles, a smokefree UK, microbubbles and how scientists in the US are trying to break cancer cells’ ‘legs’. Here’s our weekly news report.
A new study has estimated the ages at which women with faults in two particular genes are most at risk of developing breast and ovarian cancer.
Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.
Using two immunotherapy drugs together could help treat some patients with an aggressive form of breast cancer, according to an Australian study.
The chemotherapy drug capecitabine gives patients a better quality of life and is as effective at preventing breast cancer from returning as the alternative CMF
A drug that’s already approved to treat certain ovarian cancers holds some advanced breast cancers at bay longer than standard chemotherapy.
Our research has led to new clinical trials testing a combination of hormone therapies in women with early, double-positive breast cancer.